Biotechnology Focus Podcast

Biotechnology Focus

1 FAN
On the Biotechnology Focus Podcast we bring you the latest news, insights, and interviews from Canada's Biotechnology sector.
Best
Newest
Looking for recently uploaded episodes
Q&A with Rory Francis PEI BioAlliance | 099

21:51 | Oct 2nd, 2018

Q&A with Rory Francis PEI BioAlliance   099| Riding the biotech current to PEI  Welcome to another episode of Biotechnology Focus Radio. I am your host – Michelle Currie. Today, I am joined with a special guest, the executive director of the PEI ...Show More
Q&A with CDRD’s President and CEO Gordon McCauley | 098

21:25 | Sep 25th, 2018

Q&A with CDRD’s President and CEO Gordon McCauley   Taking it up another notch: CDRD discusses the newest addition to their Academy  Welcome to another episode of Biotechnology Focus Radio. I am your host – Michelle Currie. Today, I am joined wit...Show More
Revolutionary research breaks the frontline against HIV and cancer | 097

15:37 | Sep 17th, 2018

Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the Canadian biotech rundown from coast to coast. This week there has been some revolutionary research in HIV, and natural killer cells. FACI...Show More
With great growth, comes great responsibility | 096

16:29 | Sep 12th, 2018

Welcome to another episode of Biotechnology focus radio! I am your host – Michelle Currie – here to give you the rundown on what is happening in the life sciences sector from coast to coast. This week brought new collaborations, new cohorts, and new ...Show More
Even at the forefront of change… what’s next? | 095

17:16 | Aug 28th, 2018

Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what is happening in biotech across the country from coast to coast. There have been some interesting developments in the last...Show More
Shining the spotlight on Global Biotech Week Interview with Andrew Casey, BIOTECanada | 094

21:26 | Aug 21st, 2018

On the line, I have Andrew Casey who is the president and CEO of BIOTECanada. He is responsible for the day-to-day operations of the association and is the primary spokesperson for Canada’s biotech industry communicating on the industry’s behalf of g...Show More
Would you pass the salt? | 093

13:32 | Aug 14th, 2018

This week brings around new research from an international study that claims an average sodium intake does not harm your health; NSERC grants 1.65 million for a new biomedical technology program; Prometic Life Sciences elucidates the mechanism of act...Show More
Innovation is Everywhere | 092

15:15 | Aug 7th, 2018

Even though we have been having a terrific summer, innovation doesn’t just stop when the sun is beckoning, and the cottage is calling our name. It persists through rain and shine, and never has that been truer. Keep listening to find out what’s new t...Show More
Discovering biomarkers and new potential therapies | 091

13:55 | Jul 31st, 2018

Welcome to another episode of Biotechnology Focus radio. I am your host – Michelle Currie – here to give you the lowdown on the Canadian biotech scene. This episode I will be discussing how new biomarkers found in maternal blood could prevent stillbi...Show More
Canada in the limelight | 090

15:44 | Jul 24th, 2018

Welcome to another episode of Biotechnology Focus radio. I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene! Coming up we have some inspiring research from the University of Alberta regarding viral pathogen ...Show More
Changing the face of disease and pain | 089

16:05 | Jun 4th, 2018

This week we have some encouraging findings on Alzheimer’s as researchers hunt for a cure, there were two research studies released from the University of Toronto: one involving aneurysms, and the other discussing ‘invisible’ pain, as well as, a rece...Show More
Canada springs to motion, and not just with the weather | 088

18:01 | May 29th, 2018

Welcome back to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene. So, as many of you know, we are coming up to a very busy and exciting time of the year, as BI...Show More
Shifting thoughts and actions | 087

17:08 | May 4th, 2018

087 | Shifting thoughts and actions     Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene. This week sheds light on antibacterial resistance and...Show More
Paving the way of the future | 086

13:43 | Apr 17th, 2018

086 | Paving the way of the future      Welcome to another episode of Biotechnology Focus radio! This week Toronto got their socks knocked off by an announcement from Sanofi; a Chinese company expresses interest in some of Canada’s regenerative ...Show More
When it sounds more sci-fi than fact | 085

14:30 | Apr 3rd, 2018

085 | When it sounds more sci-fi than fact  Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s happening on the Canadian biotech scene! This week we have some revolutio...Show More
Canada Talks Pharma | 084

14:01 | Mar 26th, 2018

Welcome to another episode of Biotechnology Focus radio – I am your host Michelle Currie. This week I will share with you an interesting article that I came across and then we will move on to the foremost part of the episode with Vatche Bartekian, he...Show More
Anywhere from infectious diseases to splicing and dicing RNA | 083

13:15 | Mar 19th, 2018

Welcome to another episode of Biotechnology Focus radio! I am your host, Michelle Currie, here to give you the rundown on Canada’s biotech scene. This week we have stories about a possible Ebola treatment, how there may be a link between an increase ...Show More
Discoveries: contending with the superbugs | 082

12:08 | Mar 12th, 2018

082 | Discoveries: contending with the superbugs  Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s happening on the Canadian biotech scene. This week there have been ...Show More
Life sciences is abuzz for Canadians | 081

14:14 | Mar 6th, 2018

Welcome to another episode of Biotechnology Focus radio. I am your host – Michelle Currie – here to give you the rundown on the Canadian biotech scene. This week I’ll be discussing how the regenerative medicine community is abuzz, expanding personali...Show More
Pursuing cures and advancing innovation | 080

17:14 | Feb 27th, 2018

080 | Pursuing cures and advancing innovation   Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s been happening on Canada’s biotech scene. It has been a busy last cou...Show More
079 | Acknowledging some of the industry’s best

12:04 | Feb 20th, 2018

079 | Acknowledging some of the industry’s best Welcome to another episode of Biotechnology Focus radio. I am your host, Michelle Currie, here to give you the lowdown on the Canadian biotech scene. Today, I will be discussing such topics as empathic ...Show More
078 | Investing, combating and treating

11:48 | Feb 12th, 2018

Welcome to another episode of Biotechnology Focus radio. This week we are discussing a recent investment, the engineering of a CAR molecule to combat cancer, a new surgical treatment and a study notifying us that viruses are literally falling to Eart...Show More
077 | Mergers, grants and machines

11:08 | Feb 6th, 2018

Welcome to another episode of Biotechnology Focus radio. This week we are discussing some of the recent mergers and acquisitions that have been rocking the headlines, some recently awarded grants and how machines are moving fast. I am your host Miche...Show More
076 | Regulations, Drug Discovery, and Collaborations

12:38 | Jan 29th, 2018

076 | Regulations, Drug Discovery, and Collaborations Welcome to another episode of Biotechnology Focus radio. This week we’ll be discussing regulations when working with drugs, financing drug discoveries, and an East Coast collaboration that will de...Show More
075 | Partnerships, potential cures and pandemics

12:41 | Jan 22nd, 2018

075 | Partnerships, potential cures and pandemics      Welcome to another episode of Biotechnology Focus radio. This week has brought new partnerships and novel research to light from across Canada.   An international partnership sets its s...Show More
074 | An unprecedented act of kindness, a jump in cancer immunotherapy, and trusting your gut

09:56 | Jan 17th, 2018

074 | An unprecedented act of kindness, a jump in cancer immunotherapy, and trusting your gut On this episode of Biotechnology Focus radio are some of the top stories this week: How an unprecedented act of kindness will transform lives Promising news...Show More
073 | Digitalizing clinical trials, dangerous vaccines and hope for HIV

10:20 | Jan 8th, 2018

Happy 2018 from Biotechnology Focus! Ahead on today’s episode are some of the headlines that are shaking things up in the new year.   Sanofi launches digital clinical trials for increased probability of participation  A repurposed drug could be t...Show More
072 | ImmunoBiochem is haloed with angel investors, BioTalent Canada provides subsidy for more “green jobs”, giving the gift of sight and more

09:29 | Dec 19th, 2017

Ahead of Biotechnology Focus radio are some of the highlights of the week. ImmunoBiochem is haloed with angel investors after completing a new round of financing. Biotalent Canada provides subsidy to fund more “green jobs” for young graduates. eSight...Show More
071 | Alzheimer's might be a whole-body problem, key protein identified, real-time study of astronauts and more

09:59 | Dec 12th, 2017

Ahead on Biotechnology Focus radio are some of the stories from universities across the country and their innovative research this week. The University of British Columbia presents research that Alzheimer’s might be a whole-body problem. The Universi...Show More
070 | Outsourcing Podcast with Michael Stopay from Pacer Air Freight

13:14 | Dec 4th, 2017

Hi! This is Michelle Currie and on this episode of Biotechnology Focus radio, we will be discussing outsourcing. A topic defined as “the strategic use of outside resources to perform activities traditionally handled by internal staff and resources.” ...Show More
069 | Drug companies fined, new digital pill, Mississauga - A stem hub for success

10:28 | Nov 28th, 2017

The field of biotechnology is constantly evolving. It encompasses everything that harnesses cellular and biomolecular processes to develop technologies and products that will improve our lives and the health of our planet. This is Michelle Currie wit...Show More
068 | More takeaways from 2017 Bio Employee Survey

08:29 | Oct 17th, 2017

In the previous episode of the Biotechnology Focus podcast, we heard from Dean Fulford, vice-president of Stratford Managers Corp. talked about the impact that a younger cohort of workers on the biotech industry. We’re still on the topic of the 2017 ...Show More
067 | 2017 Bio Employee Survey – The millennials want to be heard

14:21 | Oct 10th, 2017

In this episode of the Biotechnology Podcast, Dean Fulford, vice-president of HR consulting for Stratford Managers Corp. discusses some key points from the recently concluded 2017 Bio Employee Survey conducted by Biotechnology Focus, Stratford Manage...Show More
066 | 2017 Bio Employee Survey results reveal encouraging workplace trend

16:32 | Sep 27th, 2017

The results of this year’s Bio Employee Survey are in. And for this week’s episode of the Biotechnology Focus podcast, we’re providing you with an exclusive sneak peek of what the pollsters found. The follow-on poll to Canada’s first-ever biotech and...Show More
065 | 3SBIO purchase Therapure Biopharma, a CAR-T trial patient dies, and Mavenclad makes a breakthrough

08:28 | Sep 12th, 2017

China’s 3SBio gains a North American through its $290 million purchase of Canada’s Therapure Biopharma Marck’s cladribine tablet Mavenclad achieves sustained control of relapsing multiple sclerosis. A patient enrolled in a CAR-T trial dies. I’m Nesto...Show More
064 | BioTalent Canada chief talks about the life science talent gap

17:24 | Sep 6th, 2017

In this episode of the Biotechnology Focus podcast, Rob Henderson, the president and CEO of BioTalent Canada, discusses what can be done to avert a life science industry talent shortage and why it is important to take the pulse of the sector's workfo...Show More
063 | Canadian life science industry HR survey

19:15 | Aug 29th, 2017

What are the things that employees in Canada’s life sciences sector value about their workplace? What attributes of their organization keep them engage and productive each day? How can you, as an employer attract and retain great talent? How can you,...Show More
062 | Pancreatic cancer treatment, three HIV drugs, farewell to Mario Lebrun

05:51 | Aug 22nd, 2017

Mario Lebrun, former BIO Quebec managing director passes away, Mylan introduces three generic drugs for HIV, and Shire Pharma’s Onivide has been approved for metastatic adeno carcinoma of the pancreas. In this week’s Biotechnology Focus Podcast, we o...Show More
060 | Intellipharmaceutics’ face lawsuit over tamper resistant opioid, IDT tackles CRISPR off-targets

07:43 | Aug 8th, 2017

The ups and down of an Ontario-based pharma company seeking to develop a solution for the world’s deadly opioid epidemic. A custom DNA nucleotide maker locks in on the problem of CRISP Cas9 off-targets I’m Nestor Arellano. And these are the biotech n...Show More
059 | Creative Destruction, lime disease defence, cell therapy for pets

13:11 | Jul 31st, 2017

Creative Destruction Lab probably conjures up images of exploding beakers and test tubes, or worse a company that demolishes buildings. If you’re a researcher or scientist working on potential new treatment or therapy. If you’re a founder or a fledgl...Show More
O58 | Michael May of CCRM talks about how to make the perfect pitch

09:23 | Jul 25th, 2017

And, that was Dr. Christopher Gemmiti, a regenerative medicine professional, making a pitch before a panel of judges, for his company RedactBio. This was during the Perfect Pitch competition held at the recent Toronto conference The Business of Regen...Show More
057 | Vatche Bartekian of Vantage Bio Trials speaks about Canada Talks Pharma 2017

14:43 | Jul 18th, 2017

From September 11th to the 12th this year, Vantage Bio trials will be holding its 2nd annual Canada Talks Pharma conference. The event is an opportunity for professionals in the biotechnology and pharmaceutical industries to get together, exchange vi...Show More
056 | Merck’s new cholesterol pill, PlantForm goes to Brazil, and Mississauga shed its Pill Hill image

20:50 | Jul 4th, 2017

In this episode of the Biotechnology Podcast, we report of the successful results of Merck’s anacetrapib trials. Dr. Don Stewart, principal of Canadian biotech firm PlantForm discusses why his company is building a laboratory in Brazil. We also take ...Show More
055 | Interview with Gordon McCauley, President and CEO of the Centre For Drug Research and Development

06:04 | Jun 13th, 2017

By now, it’s no longer a surprise for anyone that the medical marijuana market in the country is geared for explosive growth. Recently Canada’s national drug development and commercialization centre has partnered with Vancouver’s Aequus Pharmaceutica...Show More
054 |CRISPR warnings, Tragically and medical cannabis, U of G genome researchers and more

08:11 | Jun 6th, 2017

CRISPR genome editing could hold the key for treating and curing diseases such as cancer, leukemia, and HIV/AIDS. But However, Dr. J. Keith Joung of Massachusetts General Hospital warns there is growing evidence that CRISPR could alter regions of the...Show More
Winterlight Labs' Liam Kaufman on using AI to detect cognitive conditions

19:26 | May 18th, 2017

In this episode of the Biotechnology Focus Radio, Liam Kaufman, co-founder of Winterlight Labs discusses with us how AI is powering his company’s speech-based diagnostic platform. This platform natural speech to detect and monitor dementia, aphasia, ...Show More
052 | Merus Sintrom, Commense, and McPeak-Sirois with the Quebec Breast Cancer Foundation

05:35 | May 15th, 2017

In this episode of the Biotechnology Focus Radio, we discuss the approval in Spain of Merus Lab's Sintrom medication.   Microbiome research firm Commense licenses from the University of British Columbia, a biotherapeutic for preventing childhood asth...Show More
051 | Science Minister Kirsty Duncan speaks on biotechnology and innovation

05:27 | May 8th, 2017

At a recent Mississauga Board of Trade event, we caught up with Canada’s Science Minister, the Hon. Kirsty Duncan. Fresh from her trip to Washington, where she spoke with American scientists and championed the need for greater cross-border collaborat...Show More
049 | Microdermics and its quest for less painful injections

08:31 | Apr 26th, 2017

Over 1 billion people around the world suffer from "needle phobia." Each year, there are countless people who avoid critical therapies and vaccinations simply because of their fear of hypodermic needles. Vancouver's Microdermics Inc.is determined to ...Show More
048 | In the news: BDC, Appili Therapeutics and Prometic Life Sciences!

12:27 | Apr 19th, 2017

BDC launches a new program to move the needle on innovation in Canada, Appili Therapeutics snags another IRAP funding round, Prometic completes the filing of its plasminogen Biologics license application with the FDA, plus more in our rundown of the ...Show More
046 | Construction begins on EspaceLabz and this year's Gairdner Award recipients named

11:27 | Apr 3rd, 2017

Construction begins on a new multi-tenant home for young life science companies in Quebec, the Garidner Foundation names its 2017 Canada Gairdner Award winners with two Canadians among the seven winners, and Dr. Alan Bernstein adds another prestigiou...Show More
045 | Reaction to Budget 2017 and what it means to Canadian biotech

25:03 | Mar 28th, 2017

Show Notes: In the news this week, the 2017 federal budget is out and we go one-on-one with BIOTECanada’s Andrew Casey to find out if it delivers on the promise of an Innovation Agenda, the NRC and the Centre for the Commercialization of Antibodies a...Show More
044 | NeuroCDRD, the invention of a new molecular barcode technology and a huge public offering

13:34 | Mar 21st, 2017

In the news this week, the launch of NeuroCDRD – a new initiative to accelerate development of treatments for neuro diseases; OICR researchers invent a new molecular barcode technology; and Aurinia Phramceuticals prices a US$150.5 million public offe...Show More
043 | This Week in Biotech: Canadian Regenerative Medicine Alliance, and Genetic Discrimination Act Bill gets passed

10:56 | Mar 14th, 2017

Coming up on Biotechnology Focus Radio: The launch of a new Canadian Regenerative Medicine Alliance, Canada’s House of Commons passes the Genetic Discrimination Act Bill S-201, and a One-Two Punch that May Floor the Worst Infections by stopping antib...Show More
042 | Bellus Health back in the game, BC Cancer Agency makes two breakthrough discoveries, and RepliCel Life Sciences gets a little help from its friends.

14:09 | Mar 7th, 2017

Ahead on Biotechnology Focus Radio : Bellus Health back in the game with a new therapeutic asset, BC Cancer Agency scientists make two breakthrough discoveries, and RepliCel Life Sciences gets by with a little help from its friends. We have this and ...Show More
041 | A big money raise by Fusion and BioTalent Canada's newest report hits the streets

09:53 | Feb 28th, 2017

Coming up on Biotechnology Focus Radio :  Toronto’s Fusion Pharmaceuticals closes a US$25M Series A financing round led by Johnson & Johnson Innovation and BioTalent Canada releases Paving the Way, its latest labour market report. We have this and mu...Show More
040 | Future of made-in-Canada CAR-T cells looks bright, Roche Canada and Merck launch their own individual collaborative cancer research initiatives, and more

13:03 | Feb 21st, 2017

Coming up on Biotechnology Focus Radio : The future of made-in-Canada CAR-T cells looks bright, Roche Canada and Merck each launch their own individual collaborative cancer research initiatives, and using immunotherapies to kill brain cancer Welcome ...Show More
039 | MaRS West Tower turnaround, CQDM and Brain Canada team up, and more

10:57 | Feb 14th, 2017

On this weeks show, and amazing turnaround in the fortunes of the MaRS West Tower, CQDM and Brain Canada team up once again, and a significant step in the fight against cancer. We have all this and more on this week’s Biotechnology Focus Radio Show P...Show More
038 | Precision medicine for cancer patients and tackling antibiotic resistance in humans

11:22 | Feb 7th, 2017

On this weeks show, Accelerating precision medicine for cancer patients, Avivagen partners with NRC to tackle antibiotic resistance in humans, and Knight buys in on an Israeli biotech, We have all this and more on this week’s Biotechnology Focus Radi...Show More
035 | Pfizer partners with a Canadian biotech, Quark Ventures rolling out dollars and Bloom Burton and Co to host first award gala

11:37 | Jan 19th, 2017

Coming up on this week’s show: Pfizer partners with a Canadian biotech on a new therapeutic antibody discovery project, Quark Ventures keeps rolling out the dollars and Bloom Burton & Co. to host its first award gala. We have all this and more on thi...Show More
034 | Versant closes oversubscribed sixth healthcare-focused fund

11:19 | Jan 10th, 2017

Versant Ventures closes its newest fund, a new stem cell company is born in the MaRs Discovery District and Auven Therapeutics official pulls the plug on the KIACTA™ AA amyloidosis program. We have all this and more for you this week on Biotechnology...Show More
033 | Our Rundown of CETA stories, plus a blood test to diagnose concussions

12:04 | Nov 15th, 2016

Industry insiders weigh in on the impact of the Comprehensive Economic and Trade Agreement, the 2017 World Congress on Industrial Biotechnology set to return to Montreal, and a simple blood test that better diagnoses concussions.
031 |Canadian made Ebola vaccine enters the next phase of clinical trials

11:06 | Nov 3rd, 2016

On this week’s show…A Canadian made Ebola vaccine enters the next phase of clinical trials, a major Canadian generics company goes into restructuring mode, a young VC fund based in Vancouver makes it known it wants to be a major player on the life sc...Show More
029 | Canadian biotech community grows by two & TO Health!’s new online health hub!

13:16 | Sep 29th, 2016

Two new biotech companies launched, TO Health! launches a new online health hub, and Government flexes its financial muscle backing science initiatives across the nation. We have this and more on this week’s show! Welcome to Biotechnology Focus Podca...Show More
028_Genetic Discrimination: Creating a New Canadian Law

14:07 | Sep 12th, 2016

On today’s show, we go one-on- one with Borden ladner Gervais’ Jeff Graham to discuss his article in our latest issue of Biotechnology Focus Magazine, Genetic Discrimination: Creating a New Canadian Law, plus we look at the week that was and the top ...Show More
027_Cynapsus Therapeutics scores a landmark exit deal

16:33 | Sep 9th, 2016

Welcome to Biotechnology Focus Podcast. I’m your host Shawn Lawrence. We kick things off this week with the release of our latest issue of Biotechnology Focus and as such we thought we should give you our listeners a rundown or sneak peak of all the ...Show More
026_GE, ProMetic, Zymeworks, cell therapies, vaccines and more!

13:31 | Aug 30th, 2016

Zymeworks, ProMetic Life Sciences, Innovative Targeting Solutions all back in the news again; Saskatchewan researchers make a breakthrough on a devastating pig virus, and healthcare behemoth GE partners with STEMCELL Technologies.We have this and mor...Show More
ProMetic Life Science Hits 2 Clinical Milestones, Antibe Therapeutics, & Wine

15:42 | Aug 23rd, 2016

ProMetic Life Science hits two significant clinical milestones, Antibe Therapeutics reports promising Phase 2 results, In BC researchers, take a closer look at the DNA of the world’s greatest wines, and using genomics to treat and track tuberculosis ...Show More
024: Genome Canada funding, DelMar Pharma joins NASDAQ, Transition gets acquired & HOT BUTTON SURVEY Extended

13:12 | Jul 19th, 2016

Genome Canada names its latest GAPP Recipients, DelMar Pharma lists on NASDAQ, and OPKO health acquires Toronto’s Transition Therapeutics. We have this and more on this week’s Biotechnology Focus Podcast! Welcome to Biotechnology Focus Podcast. I’m y...Show More
023: VC money starts flowing into Canada, but how big is biotech's piece of the action?

21:20 | Jul 5th, 2016

Biotechnology Focus senior writer Shawn Lawrence goes one-on-one with Mike Woollatt, chief executive officer of the Canadian Venture Capital & Private Equity Association (CVCA), to discuss the upswing of venture capital investment in Canada, and to f...Show More
022: Bellus Health reels, QLT's merger, & we relaunch our "Hot Button Issue Survey"

11:41 | Jun 29th, 2016

Bellus Health is left reeling as its lead drug Kiacta fails its Phase 3 clinical study, Vancouver based QLT inks a merger deal with Aegerion Pharmaceuticals and looks to a fresh new start, and Biotechnology Focus relaunches its Hot Button Issue Surve...Show More
021_Theratechnologies Bid Denied, AmorChem KNOCK OUT, & New Commercialization Hub in Sarnia-Lambton

13:09 | Jun 21st, 2016

Our first story takes us to Southwestern Ontario, where the government of Ontario and Bioindustrial Innovation Canada have partnered to launch a new commercialization hub in Sarnia-Lambton As part of the partnership, the Government of Ontario says it...Show More
020 - Canada shines at BIO2016, Merck backs another BC antibody developer & MUCH MORE!

15:21 | Jun 14th, 2016

On this week’s show, we recap all the Canadian news coming out of the San Francisco and BIO2016, including: four announcements from the Quebec delegation, Valeant makes manufacturing moves, Merck backs another BC antibody developer and much more! ht...Show More
019: The release of our June/July issue, BIOTECanada names two Gold Leaf winners & more!

12:47 | Jun 8th, 2016

On this week’s show, Hot of the Press, we rundown all the storiesfrom our June/July issue of Biotechnology Focus, BIOTECanada names of two of its Gold Leaf Award Winners, CQDM extends its reach to Germany, and ProNAi Therapeutics licenses the rights ...Show More
018: MaRS Innovation & CCRM strike deals in Israel, GM salmon get green light in Canada & much more! Podcast

10:43 | May 31st, 2016

On this week’s show, a trip to the Middle proves successful for MaRS Innovation, a Boston jury rules against BC med tech company Neovasc, Genetically modified Salmon get the green light in Canada, and researchers uncover why the drug cetuximab works ...Show More
017: JLABS comes to Toronto, plus a rundown of the April-May issue & more!

11:24 | May 25th, 2016

On this week’s show, Biotechnology Focus senior writer Shawn Lawrence breaks down the April/May issue of Biotechnology Focus, the official opening of JLABS @ Toronto and much more!
014: Interview with Gail Garland CEO of Ontario Bioscience Innovation Organization (OBIO)

13:12 | Apr 29th, 2016

In today's show, Shawn sits down with Gail Garland, CEO ofOntario Bioscience Innovation Organization (OBIO).
Breaking down the Budget

05:07 | Mar 30th, 2016

On this week’s show, Biotechnology Focus reporter Shawn Lawrence breaks down the Canadian Federal Budget for 2016. Funding for basic research gets a big boost.
One-on-one With Dr. Jacqueline Shan of Affinity Life Science and COLD-FX

27:52 | Mar 15th, 2016

On this week’s show, Biotechnology Focus senior writer Shawn Lawrence interviews Dr. Jacqueline (Jackie) Shan, founder of Afinity Life Sciences and co-discoverer of COLD-FX. Dr. Shan is well regarded in the industry for her accomplishments first and ...Show More
One-on-one with Andrew Casey BIOTECanada

27:31 | Feb 23rd, 2016

On this week’s show, Biotechnology Focus senior writer Shawn Lawrence goes one-on-one with Andrew Casey, president and CEO of BIOTECanada to discuss the impact of the new government on the Canadian biotech sector, the recently concluded JP Morgan Con...Show More